ELOX · Eloxx Pharmaceuticals, Inc.
AI read · Good for ELOX
The AI's read
These steps let Eloxx test exaluren in 2 rare kidney diseases. An earlier study saw improved kidney structures in all 3 participants, but it was small. The current studies have not reported results, and the ADPKD study's first patient is not expected until the third quarter of 2027. Its main results are expected in 2029.